vTv Therapeutics announces oral presentation at Breakthrough T1D Congress 2026
vTv Therapeutics said it will present orally at the Breakthrough T1D Clinical and Research Congress 2026.
Story updates
12:01:15 PM UTC
SquawkNews
New research spotlights hypoglycemia-related burdens in adults with type 1 diabetes using automated insulin delivery systemsHIGH POINT, N.C., Oct. 10, 2026 (GLOBE NEWSWIRE) -- vTv Therapeutics Inc. NASDAQ:VTVT, a late-stage biopharmaceutical company advancing cadisegliatin, a novel oral investigati…